n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide has been researched along with Granuloma Gangraenescens in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ALAJMO, E; ARSLAN, M; CHERUBINO, M; FERRERI, G; NEUSS, O | 1 |
1 other study(ies) available for n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Granuloma Gangraenescens
Article | Year |
---|---|
[ARE GRANULOMA GANGRAENESCENS, THE WEGENER SYNDROME AND THE CEPHALIC LOCALIZATION OF PANARTERITIS NODOSA TO BE CONSIDERED AS 3 DIFFERENT DISEASES OR 3 CLINICAL FORMS OF THE SAME DISEASE?].
Topics: Classification; Cyclic N-Oxides; Granuloma, Lethal Midline; Granulomatosis with Polyangiitis; Humans; Levamisole; Polyarteritis Nodosa | 1963 |